PCN5 - Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (PSROC).
Saved in:
| Title: | PCN5 - Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (PSROC). |
|---|---|
| Authors: | Sackeyfio, A1, Gill, J2, Hettle, R3, Siddiqui, K2, Friedlander, M4, Ledermann, JA5 |
| Source: | Value in Health. Oct2017, Vol. 20 Issue 9, pA412-A412. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2017.08.087 |
